11/01/1978 - "Bru Pel was also found to cause increases in the incorporation of 3H-thymidine of phytohemagglutinin-sensitive splenic T lymphocytes and lipopolysaccharide-sensitive splenic B lymphocytes over 3H-thymidine-incorporated values for untreated tumor controls."
11/01/1978 - "This paper presents information obtained in our model comparing findings on the effects of CP with a Brucella abortus extract (Bru-Pel; BP) and glucan (GL) on tumor growth. "
11/01/1978 - "Bru Pel treatment of tumor-bearing mice resulted in a slight reduction in tumor size, marked splenomegaly, and statistically significant reductions in the percentages of splenic T and B lymphocytes relative to untreated tumor controls. "
11/01/1978 - "Furthermore, Bru-Pel enhanced host resistance to Listeria monocytogenes, in addition to viral infections and a transplantable tumor. "
10/01/1991 - "The immunomodulatory and anti-tumor activity of Bru-Pel, an aqueous-ether extracted residue of Brucella abortus (strain 456), was investigated. "
|4.||Osteosarcoma (Osteogenic Sarcoma)
|5.||Neoplasm Metastasis (Metastasis)
|1.||Ethyl Ether (Ether)